glp-1 als Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways The Generation and Function of

Personalized plan with the option for mail delivery or in-person administration

Our guides on managing semaglutide side effects and tirzepatide fatigue cover these systemic effects in detail

The broader 2026 context matters: as of May 2026, the FDA has proposed regulatory changes affecting compounded semaglutide and tirzepatide, with a public comment period closing June 29, 2026

Today, Im excited to share a recap of what this has meant for our membersthrough the lens of our largest-ever internal analysis on how engagement with Nooms GLP-1 Companion app is associated with success on GLP-1s, as well as how key product investments we made last year have increased the stickiness of our already highly engaging digital experience

"You can't think you can get on a GLP-1 medication and it's going to completely change everything," says Madison

Insulin resistance is strongly associated with weight gain and is a risk factor for coronary artery disease, she says